[SGLT2抑制剂对心力衰竭患者的脏保护取决于心室功能:聚合分析和分析]
Sebastián Cabrera1, Daniel Vivanco2, Daniela Lizama1
1Departamento de Medicina, Sección de Nefrología, Hospital Clínico, Universidad de Chile, Santiago, Chile.
Revista medica de Chile
|July 16, 2025
概括
-葡萄糖共传递剂-2 抑制剂 (SGLT-2i) 在心力衰竭与减少喷射分数 (HFrEF) 中对脏健康有益,但在心力衰竭与保存喷射分数 (HFpEF) 中没有. 喷射分数是SGLT-2i保护的关键.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
背景情况:
- 心力衰竭 (HF) 和慢性病 (CKD) 经常共存,共享风险因素和机制.
- -葡萄糖携带载体-2 抑制剂 (SGLT-2i) 对心脏和脏有好处,但它们对HF患者功能的影响可能因射出分数 (EF) 而有所不同.
研究的目的:
- 调查SGLT-2抑制剂的性保护作用是否依赖于心力衰竭患者的喷射分数.
- 分析SGLT-2抑制剂在减少不同HF表型的重大脏不良事件 (MAKE) 的疗效.
主要方法:
- 一项对五项随机对照试验的元分析,将SGLT-2抑制剂与HF患者的安慰剂进行比较.
- 使用EPHPP评估了偏差风险. 主要脏不良事件 (MAKE) 是主要结局.
- 根据EF分组患者:心力衰竭与减少喷射率 (HFrEF; ≤40%) 和心力衰竭与保留喷射率 (HFpEF; >40%).
主要成果:
- 对23,163名患者的全球分析显示,SGLT-2i降低MAKE的趋势不显著 (RR 0.76 [0.56-1.02]).
- 在HFrEF中,SGLT-2i显著降低了MAKE (RR 0.58 [0.44-0.75],I2=0%),但在HFpEF中没有观察到脏益处 (RR 1.01 [0.83-1.23],I2=0%).
- 通过EF分层解决了异质性,表明EF是关键调节器.
结论:
- SGLT-2 抑制剂在HFrEF中表现出显著的保护作用,但在HFpEF中却没有.
- 排泄分数是影响心力衰竭中SGLT-2抑制剂对的益处的关键因素.
- 这些发现强调了基于HF表型的个性化心综合征管理的需要.
更多相关视频
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
23.8K
03:13Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
2.4K
相关概念视频
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:22Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...